On the recordMay 8, 2013
I further ask unanimous consent that the bill be read a third time and passed and the motion to reconsider be made and laid upon the table, with no intervening action or debate. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (S. 622) was ordered to be engrossed for a third reading, was read the third time, and passed, as follows: S. 622 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013''. SEC. 2. TABLE OF CONTENTS; REFERENCES IN ACT. (a) Table of Contents.--The table of contents of this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents; references in Act. TITLE I--FEES RELATING TO ANIMAL DRUGS Sec. 101. Short title; finding. Sec. 102. Definitions. Sec. 103. Authority to assess and use animal drug fees. Sec. 104. Reauthorization; reporting requirements. Sec. 105. Savings clause. Sec. 106. Effective date. Sec. 107. Sunset dates. TITLE II--FEES RELATING TO GENERIC ANIMAL DRUGS Sec. 201. Short title; finding. Sec. 202. Authority to assess and use generic new animal drug fees. Sec. 203. Reauthorization; reporting requirements. Sec. 204. Savings clause. Sec. 205. Effective date. Sec. 206. Sunset dates.…





